My research interests have been driven by my longstanding clinical interest in liver imaging and the application of novel imaging techniques to probe diffuse and focal liver disease.  My PhD in MR haemodynamic modelling in chronic liver disease, was sponsored by the Wellcome Trust and undertaken in collaboration with the Liver Failure Group (Institute for Liver and Digestive Health at the Royal Free) and the Centre for Advanced Biomedical Imaging.  My thesis successfully developed, validated and translated MRI methods to investigate the vascular pathophysiology of chronic liver disease in preclinical models of liver disease and in patients.

I have developed specific expertise in the use of phase-contrast MRI, dynamic contrast enhanced MRI and arterial spin labelling (ASL), but am also interested in the use of further MR methods for multimetric assessment of liver disease.

I am currently involved in ongoing projects towards the development of non-invasive biomarkers for portal hypertension, including the development of clinical liver ASL.